ORASURE TECHNOLOGIES, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTSOrasure Technologies Inc • August 19th, 2019 • Surgical & medical instruments & apparatus
On August 15, 2019, OraSure Technologies, Inc. (the “Company”) entered into an asset purchase agreement (the “Agreement”) between the Company and CryoConcepts, LP (“CryoConcepts”), pursuant to which the Company has agreed to sell certain assets associated with the Company’s cryosurgical systems business (the “Business”), including the Company’s professional Histofreezer product line and several private label cryosurgical products sold in the consumer market, along with related patents and trademarks, customer contracts and goodwill associated with the Business, for an aggregate purchase price of $12.0 million in cash (the “Sale”).
Asset PURCHASE AGREEMENT BY AND AMONG OraSure Technologies, Inc. (AS SELLER) AND CryoConcepts, LP (AS BUYER) DATED AS OF August 15, 2019Asset Purchase Agreement • August 19th, 2019 • Orasure Technologies Inc • Surgical & medical instruments & apparatus • Delaware
